and Forecasts in US$ Thousand by Region/Country: 2020-2027
Table 2: Tumor Ablation Technologies Global Retrospective
Market Scenario in US$ Thousand by Region/Country: 2012-2019
Table 3: Tumor Ablation Technologies Market Share Shift across
Key Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Radiofrequency Ablation (Technology) World Market by
Region/Country in US$ Thousand: 2020 to 2027
Table 5: Radiofrequency Ablation (Technology) Historic Market
Analysis by Region/Country in US$ Thousand: 2012 to 2019
Table 6: Radiofrequency Ablation (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027
Markets Worldwide in US$ Thousand: 2020 to 2027
Table 8: Microwave Ablation (Technology) Historic Market
Perspective by Region/Country in US$ Thousand: 2012 to 2019
Table 9: Microwave Ablation (Technology) Market Sales Breakdown
Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Vision Positioning Systems Market Share Shift across
Key Geographies Worldwide: 2020 VS 2027
Table 3: Camera Systems (Component) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 4: Camera Systems (Component) Market Share Breakdown of
Worldwide Sales by Region/Country: 2020 VS 2027
Table 5: Sensors (Component) Potential Growth Markets Worldwide
in US$ Million: 2020 to 2027
Table 6: Sensors (Component) Market Sales Breakdown by
Region/Country in Percentage: 2020 VS 2027
Table 7: Markers (Component) Geographic Market Spread Worldwide
in US$ Million: 2020 to 2027
Table 8: Markers (Component) Market Share Distribution in
Percentage by Region/Country: 2020 VS 2027
Table 9: Other Components (Component) World Market Estimates
Global Dilated Cardiomyopathy Therapeutics Industry
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Global Dilated Cardiomyopathy Therapeutics Industry - https://www.reportlinker.com/p05960610/?utm source=GNW
6 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Aldosterone Antagonists, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$40.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Angiotensin-Converting Enzyme (ACE) Inhibitors segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
Global Enhanced Oil Recovery (EOR) Industry
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Global Enhanced Oil Recovery (EOR) Industry - https://www.reportlinker.com/p05960616/?utm source=GNW
4 Billion by 2027, growing at a CAGR of 23.7% over the analysis period 2020-2027. Thermal EOR, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$307.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gas Injection EOR segment is readjusted to a revised 31.3% CAGR for the next 7-year period.